Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer research

Showing results (151-160 of 49,949) with videos related to

Pageof 4,995
Sort By:
Cancer Research|April 1, 1976
Treatment of acute lymphocytic leukemia by high-dose intravenous methotrexateJ J Wang, A I Freeman, L F Sinks
Cancer Research|January 19, 2000
1999 Index to volume 59
Cancer Research|October 1, 1976
Radiation-induced murine leukemia ERLD in cell cultureA M Albrecht, J L Biedler, D J Hutchison, et al.
Cancer Research|May 8, 1999
Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptorsS D Gillies, Y Lan, K M Lo, et al.
Cancer Research|February 11, 1975
Alterations in ribonuclease activities in the plasma, spleen, and thymus of tumor-bearing miceW P Drake, L P Kopyta, C C Levy, et al.
Cancer Research|December 20, 1999
Flavopiridol, a protein kinase inhibitor, down-regulates hypoxic induction of vascular endothelial growth factor expression in human monocytesG Melillo, E A Sausville, K Cloud, et al.
Cancer Research|December 20, 1999
Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell linesF G Barr, J C Fitzgerald, J P Ginsberg, et al.
Cancer Research|December 20, 1999
Tumorigenicity of human breast cancer is associated with loss of the Ca2+-activated chloride channel CLCA2A D Gruber, B U Pauli
Cancer Research|December 20, 1999
Identification, characterization, and cloning of TIP-B1, a novel protein inhibitor of tumor necrosis factor-induced lysisE S Berleth, S Nadadur, A D Henn, et al.
Cancer Research|December 20, 1999
p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomasT Hashimoto, Y Tokuchi, M Hayashi, et al.
Pageof 4,995

Showing results (151-160 of 49,949) with videos related to

Sort By:
Pageof 4,995
Cancer Research|April 1, 1976
Treatment of acute lymphocytic leukemia by high-dose intravenous methotrexateJ J Wang, A I Freeman, L F Sinks
Cancer Research|January 19, 2000
1999 Index to volume 59
Cancer Research|October 1, 1976
Radiation-induced murine leukemia ERLD in cell cultureA M Albrecht, J L Biedler, D J Hutchison, et al.
Cancer Research|May 8, 1999
Improving the efficacy of antibody-interleukin 2 fusion proteins by reducing their interaction with Fc receptorsS D Gillies, Y Lan, K M Lo, et al.
Cancer Research|February 11, 1975
Alterations in ribonuclease activities in the plasma, spleen, and thymus of tumor-bearing miceW P Drake, L P Kopyta, C C Levy, et al.
Cancer Research|December 20, 1999
Flavopiridol, a protein kinase inhibitor, down-regulates hypoxic induction of vascular endothelial growth factor expression in human monocytesG Melillo, E A Sausville, K Cloud, et al.
Cancer Research|December 20, 1999
Predominant expression of alternative PAX3 and PAX7 forms in myogenic and neural tumor cell linesF G Barr, J C Fitzgerald, J P Ginsberg, et al.
Cancer Research|December 20, 1999
Tumorigenicity of human breast cancer is associated with loss of the Ca2+-activated chloride channel CLCA2A D Gruber, B U Pauli
Cancer Research|December 20, 1999
Identification, characterization, and cloning of TIP-B1, a novel protein inhibitor of tumor necrosis factor-induced lysisE S Berleth, S Nadadur, A D Henn, et al.
Cancer Research|December 20, 1999
p53 null mutations undetected by immunohistochemical staining predict a poor outcome with early-stage non-small cell lung carcinomasT Hashimoto, Y Tokuchi, M Hayashi, et al.
Pageof 4,995